Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as...

Related Keywords

Boston ,Massachusetts ,United States ,Amanda Cray ,Company Board Of Directors ,Investor Relations Corporate Communications ,Nasdaq ,Prnewswire Fusion Pharmaceuticals Inc ,Niowave Inc ,Astrazeneca ,Fusion Pharmaceuticals ,Nasdaq Listing Rule ,Response Inhibitors ,Senior Director ,Investor Relations ,Corporate Communications ,